KM Research Hub
← 返回论文库
待处理 入排:符合 图源:待检查 入排置信度 0.96

Time-dependent recurrence patterns after curative resection for stage II/III colorectal cancer: An integrated analysis of four phase III randomized controlled trials (JCOG2310A-S4).

Keita Tashiro, Hiroki Osumi, Kozo Kataoka, Yasuhiro Shimada, Masafumi Inomata, Tetsuya Hamaguchi, Yasumasa Takii, Yusuke Suwa, Junki Mizusawa, Yusuke Sano, Takeshi Suto, Kohei Murata, Tomohiro Adachi, Hideki Ueno, Satoshi Ikeda, Koji Komori, Manabu Shiozawa, Shunsuke Tsukamoto, Atsuo Takashima, Yukihide Kanemitsu

Eur J Cancer 245 116957

PMID42520593
PMCID-
DOI10.1016/j.ejca.2026.116957
发表日期2026-07-28
入排依据:明确的 Phase III/IIIb/II-III 随机肿瘤药物试验,且报告 time-to-event 结局。
摘要

摘要

BACKGROUND: Postoperative surveillance for colorectal cancer (CRC) remains largely uniform despite potentially time-dependent recurrence hazards. Understanding temporal recurrence dynamics may help refine surveillance strategies. However, data on temporal recurrence patterns in CRC remain limited, particularly across stage, risk, and recurrence sites. METHODS: This retrospective pooled individual participant data analysis integrated four RCTs conducted by the Japan Clinical Oncology Group. A total of 3655 patients with curatively resected pathological stage (pStage) II/III CRC were analysed (816 pStage II; 2839 pStage III). Time-dependent recurrence hazards were estimated using biweight kernel-smoothed hazard functions. Peak timing was defined as the maximum hazard within the first 5 years postoperatively. Analyses were stratified by pStage, prognostic factors identified using multivariable Cox regression, and recurrence site. RESULTS: Five-year relapse-free survival (RFS) was 87.9% in pStage II and 77.0% in pStage III. Peak recurrence hazard was observed at 10.0 and 12.8 months in pStage II and III, respectively. In pStage II, age ≥ 70 years and pT4 were independent poor prognostic factors. In pStage III, age ≥ 70 years, male sex, pT4, pN2 and absence of adjuvant chemotherapy (ACT) were independently associated with poorer RFS. Patients aged < 70 years in pStage II showed earlier peak timing than those aged ≥ 70 years (9.0 versus 12.9 months). In pStage III, patients without ACT showed earlier peak timing than those receiving ACT (3.3 versus 12.8 months). Site-specific analysis showed that liver metastasis had the earliest peak recurrence hazard (8.0 months), particularly in pStage II (6.0 months). CONCLUSIONS: Postoperative recurrence hazards showed distinct temporal patterns according to pStage, prognostic factors, and metastatic sites. These findings suggest that considering not only who is at risk, but also when the risk is highest, supports the development of risk- and time-adapted postoperative surveillance strategies.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。